Ionis Pharmaceuticals to take full ownership of Akcea Therapeutics
Ionis Pharmaceuticals is set to take full ownership of Akcea Therapeutics by acquiring the remaining stake of around 24% in the latter for about $500 million in an all-cash deal. The California-based biotech company, which is engaged in RNA-targeted drug discovery and development, will buy all the shares of it didn’t own before in Akcea […]